Literature DB >> 9271377

Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.

M C Rouyez1, C Boucheron, S Gisselbrecht, I Dusanter-Fourt, F Porteu.   

Abstract

Thrombopoietin (TPO) is the major regulator of both growth and differentiation of megakaryocytes. We previously showed that both functions can be generated by TPO in the megakaryoblastic cell line UT7, in which murine Mpl was introduced, and are independently controlled by distinct regions of the cytoplasmic domain of Mpl. Particularly, residues 71 to 94 of this domain (deleted in the mutant mpl delta3) were found to be required for megakaryocytic maturation but dispensable for proliferation. We show here that TPO-induced differentiation in UT7 cells is tightly dependent on a strong, long-lasting activation of the mitogen-activated protein kinase (MAPK) pathway. Indeed, (i) in UT7-mpl cells, TPO induced a strong activation of extracellular signal-regulated kinases (ERK) which was persistent until at least 4 days in TPO-containing medium; (ii) a specific MAPK kinase (MEK) inhibitor inhibited TPO-induced megakaryocytic gene expression; (iii) the Mpl mutant mpl delta3, which displayed no maturation activity, transduced only a weak and transient ERK activation in UT7 cells; and (iv) TPO-induced megakaryocytic differentiation in UT7-mpl delta3 cells was partially restored by expression of a constitutively activated mutant of MEK. The capacity of TPO to trigger a strong and prolonged MAPK signal depended on the cell in which Mpl was introduced. In BAF3-mpl cells, TPO triggered a weak and transient ERK activation, similar to that induced in UT7-mpl delta3 cells. In these cells, no difference in MAPK activation was found between normal Mpl and mpl delta3. Thus, depending on the cellular context, several distinct regions of the cytoplasmic domain of Mpl and signaling pathways may contribute to generate quantitative variations in MAPK activation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271377      PMCID: PMC232350          DOI: 10.1128/MCB.17.9.4991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity.

Authors:  M S Qui; S H Green
Journal:  Neuron       Date:  1992-10       Impact factor: 17.173

Review 2.  Regulation of transcription by MAP kinase cascades.

Authors:  R Treisman
Journal:  Curr Opin Cell Biol       Date:  1996-04       Impact factor: 8.382

Review 3.  Function and regulation of ras.

Authors:  D R Lowy; B M Willumsen
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

4.  A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction.

Authors:  G Pelicci; L Lanfrancone; F Grignani; J McGlade; F Cavallo; G Forni; I Nicoletti; F Grignani; T Pawson; P G Pelicci
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

5.  Role of protein kinase C in T-cell antigen receptor regulation of p21ras: evidence that two p21ras regulatory pathways coexist in T cells.

Authors:  M Izquierdo; J Downward; J D Graves; D A Cantrell
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

6.  Protein kinase C alpha activates RAF-1 by direct phosphorylation.

Authors:  W Kolch; G Heidecker; G Kochs; R Hummel; H Vahidi; H Mischak; G Finkenzeller; D Marmé; U R Rapp
Journal:  Nature       Date:  1993-07-15       Impact factor: 49.962

7.  Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor.

Authors:  S Traverse; N Gomez; H Paterson; C Marshall; P Cohen
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

8.  Platelet-derived growth factor receptor mediates activation of ras through different signaling pathways in different cell types.

Authors:  T Satoh; W J Fantl; J A Escobedo; L T Williams; Y Kaziro
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

9.  Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.

Authors:  N Komatsu; H Nakauchi; A Miwa; T Ishihara; M Eguchi; M Moroi; M Okada; Y Sato; H Wada; Y Yawata
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

10.  Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal.

Authors:  R C Skoda; D C Seldin; M K Chiang; C L Peichel; T F Vogt; P Leder
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

View more
  39 in total

Review 1.  Megakaryopoiesis.

Authors:  Amy E Geddis
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

2.  Protein-arginine methyltransferase 1 suppresses megakaryocytic differentiation via modulation of the p38 MAPK pathway in K562 cells.

Authors:  Yuan-I Chang; Wei-Kai Hua; Chao-Ling Yao; Shiaw-Min Hwang; Yi-Chi Hung; Chih-Jen Kuan; Jiun-Shyang Leou; Wey-Jinq Lin
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

3.  JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.

Authors:  Rodolphe Besancenot; Damien Roos-Weil; Carole Tonetti; Hadjer Abdelouahab; Catherine Lacout; Florence Pasquier; Christophe Willekens; Philippe Rameau; Yann Lecluse; Jean-Baptiste Micol; Stefan N Constantinescu; William Vainchenker; Eric Solary; Stéphane Giraudier
Journal:  Blood       Date:  2014-08-20       Impact factor: 22.113

4.  Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.

Authors:  S Reffas; W Schlegel
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

5.  Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.

Authors:  S M Luoh; E Stefanich; G Solar; H Steinmetz; T Lipari; T I Pestina; C W Jackson; F J de Sauvage
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

6.  Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms.

Authors:  Christian A Di Buduo; Vittorio Abbonante; Caroline Marty; Francesco Moccia; Elisa Rumi; Daniela Pietra; Paolo M Soprano; Dmitry Lim; Daniele Cattaneo; Alessandra Iurlo; Umberto Gianelli; Giovanni Barosi; Vittorio Rosti; Isabelle Plo; Mario Cazzola; Alessandra Balduini
Journal:  Blood       Date:  2020-01-09       Impact factor: 22.113

Review 7.  Multiple roles of Rap1 in hematopoietic cells: complementary versus antagonistic functions.

Authors:  Philip J S Stork; Tara J Dillon
Journal:  Blood       Date:  2005-08-02       Impact factor: 22.113

8.  Thrombopoietin upregulates nucleolin mRNA and protein in thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.

Authors:  Takatoshi Ito; Mitsuhiro Fujihara; Atsushi Oda; Shinobu Wakamoto; Miki Yamaguchi; Norio Komatsu; Hiroshi Miyazaki; Hiroshi Azuma; Hisami Ikeda; Kenji Ikebuchi
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

9.  A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: implications for physiological and pathological megakaryocytic proliferation.

Authors:  Rodolphe Besancenot; Ronan Chaligné; Carole Tonetti; Florence Pasquier; Caroline Marty; Yann Lécluse; William Vainchenker; Stefan N Constantinescu; Stéphane Giraudier
Journal:  PLoS Biol       Date:  2010-09-07       Impact factor: 8.029

10.  Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation.

Authors:  Alexandra Mazharian; Steve P Watson; Sonia Séverin
Journal:  Exp Hematol       Date:  2009-07-18       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.